Nov 28, 2023
588:533
For every 533 shares held, investors received 588. The price per share adjusted from $0.29 to $0.27.
The split itself did not change the total investment value.
TME Pharma N.V. (EURONEXT:ALTME) operates in the Biotechnology industry.
TME Pharma N.V. company overviewTME Pharma N.V.'s most recent stock split was on November 28, 2023. It was a 588-for-533 forward split, so shareholders received 588 shares for every 533 they held.
TME Pharma N.V. (EURONEXT:ALTME) has split its stock 2 times: a 1-for-100 reverse split on July 28, 2022 and a 588-for-533 split on November 28, 2023.
TME Pharma N.V. has split its stock 2 times. This history records 2 splits between July 28, 2022 and November 28, 2023.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In TME Pharma N.V.'s 588-for-533 split on November 28, 2023, every 533 shares became 588 shares.
TME Pharma N.V. has not announced a new split in our records. Its most recent split was on November 28, 2023, 2 years ago. Companies announce splits in advance, and any new EURONEXT:ALTME split will appear on this page.
Already premium?